Computational insights into the binding of pimodivir to the mutated PB2 subunit of the influenza A virus

Influenza A virus (IAV) is reported to develop Pimodivir resistance because of multiple mutations within the Polymerase basic 2 protein (PB2) of IAV. The lack of a high-resolution structure of these PB2 mutants complexed with Pimodivir hinders efforts to understand the drug resistance. Here we decipher the binding differences of Pimodivir in the wild-type and mutant systems Q306H, S324I, S324N, S324R, F404Y, and N510 T of IVA PB2 using homology modelling, molecular dynamics, molecular docking, and density functional theory simulations. The key residues responsible for Pimodivir binding were identified as Glu361, Arg355, Arg332, His357, and Phe323. Those mutations, mainly N510 T, result in significant conformational changes of Pimodivir in the PB2 active site. As a result, the affinity of Pimodivir is significantly reduced in the N510 T system. The mutation effects are less pronounced in the other mutant systems. Dynamic cross-correlation matrix (DCCM) analyses suggest that the single-point mutation N510 T produces an allosteric effect on the ligand-binding domain, thus reducing ligand-binding affinity. The present study reveals how a single-point mutation modulates the Pimodivir binding in IAV PB2, which provides important insights into designing new Pimodivir analogues with better binding affinities.

Automated summary

In this study, the binding differences of Pimodivir in wild-type and mutant systems of IAV PB2 were investigated using various computational methods. The N510 T mutation was found to significantly alter the conformation of Pimodivir in the PB2 active site, resulting in reduced drug-protein affinity. The study reveals how a single-point mutation modulates Pimodivir binding in IAV PB2 and provides insights for designing new analogues with improved binding affinities.